GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: compound 161 [WO2024151547A1] | MRT6160
Compound class:
Synthetic organic
Comment: MRT-6160 is a cereblon-based molecular glue degrader. It is designed to target the Rho-family guanine nucleotide exchange factor (GEF) and adaptor protein VAV1 as a neosubstrate [3]. VAV1 is a key signaling protein downstream of both the T- and B-cell receptors that is proposed as a novel target for immunomodulator development for the treatment of hematological malignancies and autoimmune diseases [1-2,4]. Selective degradation is proposed to disrupt the GEF and scaffolding activities of VAV1.
|
|
|||||||||||||||||||||||||||||||||||
| No information available. |
Summary of Clinical Use ![]() |
| A first-in-human study of MRT-6160 in healthy subjects has been completed. |
| Clinical Trials | |||||
| Clinical Trial ID | Title | Type | Source | Comment | References |
| NCT06597799 | First-in-human Study of MRT-6160 in Healthy Subjects | Phase 1 Interventional | Monte Rosa Therapeutics, Inc | ||